TUZON Trademark

Trademark Overview


On Tuesday, July 28, 2020, a trademark application was filed for TUZON with the United States Patent and Trademark Office. The USPTO has given the TUZON trademark a serial number of 90079310. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, June 3, 2021. The TUZON trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development services; Research and development of tests for pathogenic diseases; Pathogenic disease testing and communicating those results; Biomedical and biopharmaceutical research and development; Scientific and medical research in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Consulting services in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Scientific research in the field of antibodies for use in testing, vaccine design, therapeutic agents; Consulting services in the field of antibodies for use in testing, vaccine design, therapeutic agents; Scientific research in the field of bioinformatics, sequencing, epidemiology, public health; Developing DNA-, RNA-, protein-based reagents and other biological re...
tuzon

General Information


Serial Number90079310
Word MarkTUZON
Filing DateTuesday, July 28, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, June 3, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific research and development services; Research and development of tests for pathogenic diseases; Pathogenic disease testing and communicating those results; Biomedical and biopharmaceutical research and development; Scientific and medical research in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Consulting services in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Scientific research in the field of antibodies for use in testing, vaccine design, therapeutic agents; Consulting services in the field of antibodies for use in testing, vaccine design, therapeutic agents; Scientific research in the field of bioinformatics, sequencing, epidemiology, public health; Developing DNA-, RNA-, protein-based reagents and other biological reagents in support of scientific research; Providing protocols, reagents, and other scientific information and tools in support of scientific and medical research; Developing and providing information about molecular biology research tools, specifically vectors, plasmids, nucleic acid fragments, biological libraries and entities

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 27, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBel Air, MD 21014

Trademark Events


Event DateEvent Description
Thursday, June 3, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, June 3, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, November 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 20, 2020NON-FINAL ACTION E-MAILED
Friday, November 20, 2020NON-FINAL ACTION WRITTEN
Friday, November 13, 2020ASSIGNED TO EXAMINER
Thursday, August 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 31, 2020NEW APPLICATION ENTERED IN TRAM